#STLN
#$STLN options, Nov 13: $78K in premium, 72% calls ($56K vs $22K in puts).
Dark pool activity in #$STLN hit 6.7x its usual level on Nov 13, 5-day trend rising.
Block trading this far above normal means large holders are active.

Full story at the link.
STLN Technical Levels: Chart, Options Flow and Dark Pools Diverge at $3.50
STLN at $3.50: support $3.30, resistance $5.79; the chart, options flow and dark pools point in different directions.
globaltradersacademy.com
November 16, 2026 at 9:35 AM
Richard Blumenthal's spouse sold $96K-$390K of The Oncology Institute (STLN).

Across 12 lots. Executed Sep 18, disclosed Oct 26. 38 days.

paydirt.news/filing/246099/richard-blumenthal-sold-stln

$STLN #congress #stocks #trading
Richard Blumenthal's spouse sold $96K-$390K of The Oncology Institute (STLN). · Paydirt
Executed Sep 18, disclosed Oct 26. 38 days. The filing, the filer's record, and the original document on Paydirt.
paydirt.news
November 9, 2026 at 2:08 PM
Starling Oncology ($STLN) – Insider Purchase

• Insider: Jorey Chernett, 10% owner
• Bought: 48,294 shares (about $176K)
• Price: about $3.65 a share · Nov 9
• Now Holds: 7,858,091 shares directly

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#InsiderBuying #Stocks
Jorey Chernett (10% owner) bought $176K of Starling Oncology ($STLN)
Form 4 filed Nov 10. Every line of the filing.
elixstocks.com
November 11, 2026 at 11:14 AM
$TEM-1 $Z-1 $LUMN-1 $RMBS-1 $SBIT-1 $CRWV-1 $LSCC-1 $EROC-1 $IREN-1 $VZ-1 $STLN-1 $EXEL-1 $IE-1 $TNA-1 $ASTS-1 $VKTX-1 $OSIS-1 $DIOD-1 $ALNY-1 $NTLA-1 $XLP-1 $SLV-1 $UPRO-1

Daily Wrap - Final Message: Daily Wrap up for 2026-11-13 - 2573 events.

#burst_trades #HFT #trading ...
November 13, 2026 at 9:22 PM
Starling Oncology ($STLN): Insider open-market purchase: $176K
Jorey Chernett (10% owner) bought 48,294 shares
SEC Form 4 · filed Nov 10 · last close $4.34 (Nov 10), not a live quote
#SECFilings #Stocks

Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
Starling Oncology ($STLN): Insider open-market purchase: $176K
Insider open-market purchase: $176K. Filed Nov 10. Jorey Chernett (10% owner) bought 48,294 shares. About $3.65 a share. Educational only. Not investment advice.
elixstocks.com
November 11, 2026 at 11:05 PM
ALERT 🚨: Chernett Jorey, 10% Owner, bought $176,273 of Starling Oncology, Inc. (STLN) on 2026-11-09. Chernett Jorey, 10% Owner, sold...

https://www.narrowit.com/sec/filing?cik=0001799191&accession=0000921895-26-003018&doc=xslF345X06%2Fform414528003_11102026.xml
#SEC #Form4 #InsiderTrading #STLN
Insider Trading | Narrowit.com
Insider Trading for SEC accession 0000921895 26 003018 with readable ownership transactions, filing details, and source document access.
www.narrowit.com
November 11, 2026 at 1:04 AM
New Senate STOCK Act disclosure: Richard Blumenthal reported a sale of Starling Oncology, Inc. - Common Stock (STLN). Amount: $15,001 - $50,000. Transaction date: 2026-09-22....

https://www.narrowit.com/politics-trading/5b34640a612874b54e4e
#CongressTrading #StockAct #Senate #STLN #SenateEfd
Richard Blumenthal Sale Disclosure - Starling Oncology, Inc. - Common Stock (STLN) | Narrowit.com
Richard Blumenthal filed a Senate STOCK Act disclosure reporting a sale of Starling Oncology, Inc. - Common Stock (STLN). Amount: $15,001 - $50,000. Transaction date: 2026-09-22. Filed: 2026-10-26.
www.narrowit.com
November 9, 2026 at 2:35 PM
New Senate STOCK Act disclosure: Richard Blumenthal reported a sale of Starling Oncology, Inc. - Common Stock (STLN). Amount: $1,001 - $15,000. Transaction date: 2026-09-22....

https://www.narrowit.com/politics-trading/4a0d4159187afb651fe5
#CongressTrading #StockAct #Senate #STLN #SenateEfd
Richard Blumenthal Sale Disclosure - Starling Oncology, Inc. - Common Stock (STLN) | Narrowit.com
Richard Blumenthal filed a Senate STOCK Act disclosure reporting a sale of Starling Oncology, Inc. - Common Stock (STLN). Amount: $1,001 - $15,000. Transaction date: 2026-09-22. Filed: 2026-10-26.
www.narrowit.com
November 9, 2026 at 2:34 PM
New Senate STOCK Act disclosure: Richard Blumenthal reported a sale of Starling Oncology, Inc. - Common Stock (STLN). Amount: $1,001 - $15,000. Transaction date: 2026-09-18....

https://www.narrowit.com/politics-trading/214e886c4e7b468ade21
#CongressTrading #StockAct #Senate #STLN #SenateEfd
Richard Blumenthal Sale Disclosure - Starling Oncology, Inc. - Common Stock (STLN) | Narrowit.com
Richard Blumenthal filed a Senate STOCK Act disclosure reporting a sale of Starling Oncology, Inc. - Common Stock (STLN). Amount: $1,001 - $15,000. Transaction date: 2026-09-18. Filed: 2026-10-26.
www.narrowit.com
November 9, 2026 at 2:35 PM
New Senate STOCK Act disclosure: Richard Blumenthal reported a sale of Starling Oncology, Inc. - Common Stock (STLN). Amount: $1,001 - $15,000. Transaction date: 2026-09-23....

https://www.narrowit.com/politics-trading/2079448b9f559e580b65
#CongressTrading #StockAct #Senate #STLN #SenateEfd
Richard Blumenthal Sale Disclosure - Starling Oncology, Inc. - Common Stock (STLN) | Narrowit.com
Richard Blumenthal filed a Senate STOCK Act disclosure reporting a sale of Starling Oncology, Inc. - Common Stock (STLN). Amount: $1,001 - $15,000. Transaction date: 2026-09-23. Filed: 2026-10-26.
www.narrowit.com
November 9, 2026 at 2:33 PM
11 06 26 Notable Stocks In Play according to Unusual Options Flow
www.patreon.com/posts/174623...

#$STLN
#$DLR
#$SOXX
#$CCJ
#$VSAT
#$BKD
November 7, 2026 at 2:51 AM
Starling Oncology™ (#$STLN) reported Q3 2026 results: revenue up 24.3% YoY to $169.8M, Specialty Pharmacy revenue up 44%, and Adjusted EBITDA of $3.4M, our second consecutive positive quarter. Full release: lnkd.in/eZYFdH5G

#StarlingOncology #STLN #Q3Earnings
November 5, 2026 at 9:23 PM
📰 Richard Blumenthal disclosed a $1K–$15K sale in $STLN
Read it → https://quantcapitol.com/news/richard-blumenthal-disclosed-a-1k-15k-sale-in-stln-acd66d.html
$STLN #Congress
November 5, 2026 at 1:17 AM
📰 Richard Blumenthal disclosed a $15K–$50K sale in $STLN
Read it → https://quantcapitol.com/news/richard-blumenthal-disclosed-a-15k-50k-sale-in-stln-dd7c3a.html
$STLN #Congress
November 3, 2026 at 10:17 AM
Our Chief Medical Officer and President of Practice, Yale D. Podnos, MD, MPH, FACS, joined Matthew Ko on the Beyond the Chart: Exploring the AI Frontier for Oncology podcast to discuss how AI is shaping care delivery. Listen to the full conversation now: lnkd.in/eYh5NVpS #StarlingOncology #STLN
November 4, 2026 at 2:45 PM
Sen. Richard Blumenthal (D-CT) disclosed 2 trades:
Traded: Sep 22 | Disclosed: Oct 26

Sold: #STLN ($1K-$15K), #STLN ($15K-$50K)

https://integrityindex.us/candidate/richard-blumenthal
Richard Blumenthal - Integrity Index
View Richard Blumenthal's political integrity grade, campaign financing, and conflicts of interest.
integrityindex.us
October 31, 2026 at 4:00 AM
Sen. Richard Blumenthal (D-CT) disclosed 2 trades:
Traded: Sep 18 | Disclosed: Oct 26

Sold: #STLN ($1K-$15K), #STLN ($15K-$50K)

https://integrityindex.us/candidate/richard-blumenthal
Richard Blumenthal - Integrity Index
View Richard Blumenthal's political integrity grade, campaign financing, and conflicts of interest.
integrityindex.us
October 31, 2026 at 4:00 AM
Sen. Richard Blumenthal (D-CT) disclosed 1 trade:
Traded: Sep 23 | Disclosed: Oct 26

Sold: #STLN ($1K-$15K)

https://integrityindex.us/candidate/richard-blumenthal
Richard Blumenthal - Integrity Index
View Richard Blumenthal's political integrity grade, campaign financing, and conflicts of interest.
integrityindex.us
October 31, 2026 at 12:00 AM
Richard Blumenthal (D-CT) sold $1,001 - $15,000 of STLN Starling Oncology, Inc. - Common Stock on 2026-09-23, disclosed 2026-10-26 (33 days later). https://congresstradealerts.com/trade/656565
October 29, 2026 at 9:00 PM
Richard Blumenthal (D-CT) sold $1,001 - $15,000 of STLN Starling Oncology, Inc. - Common Stock on 2026-09-22, disclosed 2026-10-26 (34 days later). https://congresstradealerts.com/trade/656561
October 29, 2026 at 9:01 PM
Richard Blumenthal (D-CT) sold $1,001 - $15,000 of STLN Starling Oncology, Inc. - Common Stock on 2026-09-18, disclosed 2026-10-26 (38 days later). https://congresstradealerts.com/trade/656562
October 29, 2026 at 9:01 PM
Richard Blumenthal (D-CT) sold $15,001 - $50,000 of STLN Starling Oncology, Inc. - Common Stock on 2026-09-22, disclosed 2026-10-26 (34 days later). https://congresstradealerts.com/trade/656563
October 29, 2026 at 9:01 PM
Richard Blumenthal (D-CT) sold $15,001 - $50,000 of STLN Starling Oncology, Inc. - Common Stock on 2026-09-18, disclosed 2026-10-26 (38 days later). https://congresstradealerts.com/trade/656564
October 29, 2026 at 9:01 PM
Starling Oncology™ (#$STLN) today announced it will release Q3 2026 financial results on Thursday, Nov. 5, followed by a conference call at 5:00 p.m. ET.
Webcast and dial-in details: investors.starlingoncology.com
Full announcement: lnkd.in/gjKBRBD6
#StarlingOncology #STLN
October 26, 2026 at 2:08 PM